Drug Shortage Report for MYLAN-METFORMIN
| Report ID | 3935 |
| Drug Identification Number | 02148765 |
| Brand name | MYLAN-METFORMIN |
| Common or Proper name | METFORMIN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BT, 360BT, 500BT |
| ATC code | A10BA |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-07-03 |
| Actual start date | 2018-07-03 |
| Estimated end date | Unknown |
| Actual end date | 2018-07-03 |
| Shortage status | Resolved |
| Updated date | 2018-07-05 |
| Company comments | Discontinued in ID 53757 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v33 | 2018-07-05 | French | Compare |
| v32 | 2018-07-05 | English | Compare |
| v31 | 2018-07-04 | English | Compare |
| v30 | 2018-07-03 | French | Compare |
| v29 | 2018-07-03 | French | Compare |
| v28 | 2018-07-03 | English | Compare |
| v27 | 2018-07-03 | French | Compare |
| v26 | 2018-07-03 | English | Compare |
| v25 | 2018-06-05 | French | Compare |
| v24 | 2018-06-05 | English | Compare |
| v23 | 2017-12-23 | English | Compare |
| v22 | 2017-12-22 | French | Compare |
| v21 | 2017-12-22 | English | Compare |
| v20 | 2017-11-29 | French | Compare |
| v19 | 2017-11-29 | English | Compare |
| v18 | 2017-11-07 | French | Compare |
| v17 | 2017-11-07 | English | Compare |
| v16 | 2017-10-11 | French | Compare |
| v15 | 2017-10-11 | English | Compare |
| v14 | 2017-10-11 | English | Compare |